Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
RCUSArcus Biosciences, Inc.
| Figure | RCUSArcus Biosciences, Inc.FY2025 · Dec |
|---|---|
| Revenue | $247.00M |
| Revenue, yoy | −4.3% |
| Net income | $353.00M |
| Net income, yoy | −24.7% |
| Net margin | -142.9% |
| Free cash flow | $484.00M |
| FCF margin | -196.0% |
| EPS, diluted | $3.29 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed